Add
MAPP to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| MAPP > SEC Filings for MAPP > Form 8-K on 12-Nov-2008 | All Recent SEC Filings |
12-Nov-2008
Results of Operations and Financial Condition, Financial Statements and
On November 12, 2008, MAP Pharmaceuticals, Inc. ("MAP") issued a press release announcing its financial results for its third quarter ended September 30, 2008. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 of this Current Report on Form 8-K and the information contained in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Item 2.02 of this Current Report on Form 8-K and the press release referenced herein is not incorporated by reference into any filings of MAP under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing, unless explicitly incorporated by specific reference into such filing.
(d) Exhibits
Exhibit No. Description
99.1 Press Release of MAP Pharmaceuticals, Inc., dated November 12, 2008.
|
|